{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T17:07:34Z","timestamp":1758042454560,"version":"3.44.0"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,11]]},"DOI":"10.7759\/cureus.92072","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T16:02:04Z","timestamp":1757606524000},"source":"Crossref","is-referenced-by-count":0,"title":["Beyond the Blot: Diagnostic Challenges in Atypical Dermatomyositis With Overlapping Myasthenia Gravis"],"prefix":"10.7759","author":[{"given":"Syed Mashood","family":"Iqbal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veena","family":"Jayaramu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sankar Ram","family":"Ragasankar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadiya","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.23736\/S2784-8671.23.07458-3","article-title":"Dermatomyositis: a comprehensive review of clinical manifestations, serological features, and therapeutic approaches","volume":"158","author":"Didona D","year":"2023","unstructured":"Didona D, Solimani F, Caposiena Caro RD, et al.. Dermatomyositis: a comprehensive review of clinical manifestations, serological features, and therapeutic approaches. Ital J Dermatol Venerol. 2023, 158:84-98. 10.23736\/S2784-8671.23.07458-3","journal-title":"Ital J Dermatol Venerol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-019-0871-4","article-title":"Juvenile dermatomyositis-clinical phenotypes","volume":"21","author":"Li D","year":"2019","unstructured":"Li D, Tansley SL. Juvenile dermatomyositis-clinical phenotypes. Curr Rheumatol Rep. 2019, 21:74. 10.1007\/s11926-019-0871-4","journal-title":"Curr Rheumatol Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2013.12.005","article-title":"The co-existence of myasthenia gravis in patients with myositis: a case series","volume":"43","author":"Paik JJ","year":"2014","unstructured":"Paik JJ, Corse AM, Mammen AL. The co-existence of myasthenia gravis in patients with myositis: a case series. Semin Arthritis Rheum. 2014, 43:792-6. 10.1016\/j.semarthrit.2013.12.005","journal-title":"Semin Arthritis Rheum"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000001091","article-title":"Update on dermatomyositis","volume":"35","author":"Tanboon J","year":"2022","unstructured":"Tanboon J, Nishino I. Update on dermatomyositis. Curr Opin Neurol. 2022, 35:611-21. 10.1097\/WCO.0000000000001091","journal-title":"Curr Opin Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2011.63","article-title":"Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis","volume":"7","author":"Mammen AL","year":"2011","unstructured":"Mammen AL. Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis. Nat Rev Neurol. 2011, 7:343-54. 10.1038\/nrneurol.2011.63","journal-title":"Nat Rev Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.reumae.2014.12.008","article-title":"Dermatomyositis and myasthenia gravis: an uncommon association with therapeutic implications","volume":"11","author":"G\u00f3mez CS","year":"2015","unstructured":"G\u00f3mez CS, Robles BJF, Perles CM, Barbadillo C, Godoy H, Andr\u00e9u JL. Dermatomyositis and myasthenia gravis: an uncommon association with therapeutic implications. Reumatol Clin. 2015, 11:244-246. 10.1016\/j.reumae.2014.12.008","journal-title":"Reumatol Clin"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez623","article-title":"A reverse translational study on the effect of rituximab, rituximab plus belimumab, or bortezomib on the humoral autoimmune response in SLE","volume":"59","author":"van Dam LS","year":"2020","unstructured":"van Dam LS, Osmani Z, Kamerling SW, et al.. A reverse translational study on the effect of rituximab, rituximab plus belimumab, or bortezomib on the humoral autoimmune response in SLE. Rheumatology (Oxford). 2020, 59:2734-45. 10.1093\/rheumatology\/kez623","journal-title":"Rheumatology (Oxford)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/396479-beyond-the-blot-diagnostic-challenges-in-atypical-dermatomyositis-with-overlapping-myasthenia-gravis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T16:02:05Z","timestamp":1757606525000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/396479-beyond-the-blot-diagnostic-challenges-in-atypical-dermatomyositis-with-overlapping-myasthenia-gravis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,11]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.92072","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,9,11]]}}}